TERESA SOWA: Open Payments
NPI 1699328443 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 30 payments from 10 companies in 2025. Trend: 2023 $1,186 · 2024 $1,707 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $90 |
| ABBVIE INC. | 5 | $74 |
| PFIZER INC. | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Novo Nordisk Inc | 3 | $49 |
| Exact Sciences Corporation | 2 | $35 |
| Amgen Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: FARXIGA, Kerendia, JARDIANCE, BREZTRI, PAXLOVID, Ozempic, VRAYLAR, EVENITY.
Industry payments across TX — which companies pay providers there.
